Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.2T, Eli Lilly(LLY) trades at $1,269.53. The stock has a price-to-earnings ratio of 43.62 and currently yields dividends of 0.52%.
During the trading session on 2026-10-21, Eli Lilly(LLY) shares reached a daily high of $1,279.28 and a low of $1,261.69. At a current price of $1,269.53, the stock is +0.6% higher than the low and still -0.8% under the high.
Trading activity shows a volume of 824.09K, compared to an average daily volume of 2.42M.
The stock's 52-week range extends from a low of $793.82 to a high of $1,311.75.
The stock's 52-week range extends from a low of $793.82 to a high of $1,311.75.
LLY News
...
Leerink raised the firm’s price target on Eli Lilly (LLY) to $1,316 from $1,309 and keeps an Outperform rating on the shares. The firm’s investment thesis is th...
The stock of pharmaceutical giant Eli Lilly (LLY) has hit an all-time high on Oct. 20. Shares of the weight-loss drug maker reached an intraday record high of $...
Analyst ratings
85%
of 33 ratingsMore LLY News
Investing Eli Lilly Rises 4% While Foundayo Nears European Approval; Amgen and Novo Nordisk Edge Higher A European regulatory endorsement for an oral obesity pi...
As of 11:36 AM ET, the Dow Jones Industrial Average (^DJI +0.95%) is up 0.91% to 52,437 as blue-chips outperform, while the S&P 500 (^GSPC +0.37%) has climbed 0...
Eli Lilly just posted 47.7% revenue growth and its weight-loss drugs are reshaping global healthcare, but whether that momentum turns a four-year investment int...
Goldman Sachs raised the firm’s price target on Eli Lilly (LLY) to $1,413 from $1,371 and keeps a Buy rating on the shares. Eli Lilly is expected to deliver ano...
Pennsylvania filed a lawsuit against Eli Lilly (NYSE:LLY) and other defendants on Oct. 20, 2026, alleging coordinated insulin price inflation. The complaint cl...
Eli Lilly just crushed earnings again and sits within striking distance of its all-time high, but a looming price war with Novo Nordisk and a dangerously concen...
Eli Lilly (LLY -0.92%) is expanding access at lower realized prices while its margins continue to improve. That unusual combination could become even more impor...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.